1. Maan JS, Ershadi M, Khan I, Saadabadi A. Quetiapine. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023 http://www.ncbi.nlm.nih.gov/books/NBK459145/
2. Iqbal Y, Connell C, Worthington M, Elrafei H, Mulvaney CA, Kaewchaluay C. Quetiapine dose for people with schizophrenia. Cochrane Database Syst. Rev. 2019. https://doi.wiley.com/10.1002/14651858.CD013372
3. Stäuble CK, Lampert ML, Mikoteit T, Hatzinger M, Hersberger KE, Meyer zu Schwabedissen HE. Severe Adverse Drug Reactions to Quetiapine in Two Patients Carrying CYP2D6*4 Variants: A Case Report. Int. J. Mol. Sci. 2021;22:6480.
4. Modesto-Lowe V, Harabasz AK, Walker SA. Quetiapine for primary insomnia: Consider the risks. Cleve. Clin. J. Med. 2021;88:286–94.
5. Curry DE, Richards BL. A Brief Review of Quetiapine. Am. J. Psychiatry Resid. J. 2022;18:20–2.
6. BPOM. Cek BPOM. 2023. https://cekbpom.pom.go.id/
8. National Center for Biotechnology Information. PubChem Compound Summary for CID 5002, Quetiapine. https://pubchem.ncbi.nlm.nih.gov/compound/Quetiapine. Accessed May 5, 2023.